TG Therapeutics, Inc. (TGTX) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 4.3B |
| Enterprise Value | 4.48B |
| P/E Ratio | 18.18 |
| PEG Ratio | 0.03 |
| Price/Sales Ratio | 10.6 |
| Price/Book Ratio | 12.99 |
| Enterprise/Revenue | 10.94 |
| Enterprise/EBITDA | 65.16 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0.55 |
| Operating Margin | 0.17 |
AD
Management Effectiveness
| Return On Assets | 0.27 |
| Return On Equity | 0.72 |
Income Statement
| Revenue | 616.29M |
| Revenue/Share | 5.64 |
| Gross Profit | 515.57M |
| EBITDA | 134.36M |
| Net Income | 447.18M |
| Diluted EPS | 2.77 |
Balance Sheet
| Total Cash | 552.25M |
| Total Cash/Share | 3.9 |
| Total Debt | 754.44M |
| Total Debt/Equity | 1.25 |
| Current Ratio | 4.27 |
| Book Value Per Share | 4.26 |
Price History
| 52-Week Change | 64.01 |
| 52-Week High | 59.3 |
| 52-Week Low | 26.76 |
| Moving Average 50 Days | 53.55 |
| Moving Average 200 Days | 41.76 |
Statistics
| Average Volume | 2.01M |
| Shares Outstanding | 153.08M |
| % Held by Institutions | 79.42 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 4:225 |
| Last Split Date | April 30, 2012 |
AD
